Omicron Variant & New Therapeutics for COVID-19
This past Feb. 7th, Dr. Chapman presented the clinical characteristics of the Omicron variant and potential for immune escape, and he provided a step wise approach to treating mild to moderate COVID-19 in patients at risk for hospitalization and disease progression. He also advised on how to use Sotrovimab, Paxlovid, and Remdesivir for this indication.
Dr. Michael Chapman Regional Division Head, Infectious Diseases, Surrey Memorial Hospital
Click here to watch the presentation on demand
View the presentation (PDF)
Related Posts
Healthcare Workers Need Our Help!
By popular request, MindWell for Healthcare Workers is available again! Program Begins: Monday,
A Physician’s Guide to Resources to Start Truth and Reconciliation
Incorporating truth and reconciliation into medical practices requires a comprehensive understan
New tech lets Surrey NICU doctors monitor babies’ ‘most important organ’
Thanks to a generous donation, Surrey Memorial’s Neo-Natal Intensive Care Unit has new tec